Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection
Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:432db3d909be41fbba6bddb8eb40f52c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:432db3d909be41fbba6bddb8eb40f52c2021-12-02T16:27:59ZChemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection10.1038/s41541-021-00360-12059-0105https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00360-1https://doaj.org/toc/2059-0105Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific autophagy mutant of Plasmodium berghei (ATG8 overexpressor), when used as a live vaccine under a CVac regimen, provides superior long-lasting protection, in both inbred and outbred mice, as compared to WT-CVac. Uniquely, the protection elicited by this mutant is predominantly dependent on a CD8+ T-cell response through an IFN-γ-independent mechanism and is associated with a stable population of antigen-experienced CD8+ T cells. Jointly, our findings support the exploitation of liver-stage mutants as vaccines under a CVac protocol. This vaccination strategy is also a powerful model to study the mechanisms of protective immunity and discover new protective antigens.Tejram SahuElla J. GehrkeYevel Flores-GarciaGodfree MlamboJulia D. RomanoIsabelle CoppensNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Tejram Sahu Ella J. Gehrke Yevel Flores-Garcia Godfree Mlambo Julia D. Romano Isabelle Coppens Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
description |
Abstract Genetically attenuated sporozoite vaccines can elicit long-lasting protection against malaria but pose risks of breakthrough infection. Chemoprophylaxis vaccination (CVac) has proven to be the most effective vaccine strategy against malaria. Here, we demonstrate that a liver stage-specific autophagy mutant of Plasmodium berghei (ATG8 overexpressor), when used as a live vaccine under a CVac regimen, provides superior long-lasting protection, in both inbred and outbred mice, as compared to WT-CVac. Uniquely, the protection elicited by this mutant is predominantly dependent on a CD8+ T-cell response through an IFN-γ-independent mechanism and is associated with a stable population of antigen-experienced CD8+ T cells. Jointly, our findings support the exploitation of liver-stage mutants as vaccines under a CVac protocol. This vaccination strategy is also a powerful model to study the mechanisms of protective immunity and discover new protective antigens. |
format |
article |
author |
Tejram Sahu Ella J. Gehrke Yevel Flores-Garcia Godfree Mlambo Julia D. Romano Isabelle Coppens |
author_facet |
Tejram Sahu Ella J. Gehrke Yevel Flores-Garcia Godfree Mlambo Julia D. Romano Isabelle Coppens |
author_sort |
Tejram Sahu |
title |
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
title_short |
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
title_full |
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
title_fullStr |
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
title_full_unstemmed |
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
title_sort |
chemoprophylaxis vaccination with a plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/432db3d909be41fbba6bddb8eb40f52c |
work_keys_str_mv |
AT tejramsahu chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection AT ellajgehrke chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection AT yevelfloresgarcia chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection AT godfreemlambo chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection AT juliadromano chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection AT isabellecoppens chemoprophylaxisvaccinationwithaplasmodiumliverstageautophagymutantaffordsenhancedandlonglastingprotection |
_version_ |
1718383925997338624 |